36 studies found for: Open Studies | "Platelet Aggregation Inhibitors"
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor
Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin
Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation
|27||Not yet recruiting||
Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Sexual Hormones and Haemostasis: Observations for Women Health
Effect of Ticagrelor on Endothelial Function
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Study of LC23-1306 in Healthy Male Subjects
Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
|35||Not yet recruiting||
Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry
† Indicates status has not been verified in more than two years